Tech Company Financing Transactions
Biocomposites Funding Round
Biocomposites, operating out of Keele, Staffordshire, secured funding from Novo Holdings and TA Associates.
Transaction Overview
Company Name
Announced On
3/3/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Keele Science Park
Keele, Staffordshire, ST5 5NL
UK
Keele, Staffordshire, ST5 5NL
UK
Phone
Website
Email Address
Not Recorded
Overview
Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds and polymers for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry and sports injuries. Biocomposites products are now used in over 1 million procedures per annum and sold in more than 100 countries around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Harris
Browse more venture capital transactions:
Prev: 3/3/2025: Instant venture capital transaction
Next: 3/3/2025: Padrea Global Services venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs